A Phase III Study to Evaluate the Efficacy and Safety of Anti-IgE Monoclonal Antibody in Allergic Asthma Patients.

Condition:   Asthma, Allergic Interventions:   Drug: CMAB007;   Drug: Symbicort;   Drug: Seretide;   Drug: Ventolin;   Drug: placebo Sponsor:   Shanghai Biomabs Pharmaceutical Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials